PDGFRB and breast cancer: Furthermore, ARHGEF1, CFAP65, PDGFRB and CLEC5A were labeled as prognostic marker by the Human Protein Atlas in renal and breast cancer, endometrial cancer, renal and urothelial cancer, and ovarian cancer, respectively [32, 33].